- Home
- PNRG vs ABEO Comparison
PNRG vs ABEO Comparison
Compare PNRG & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNRG
- ABEO
- Stock Information
- Founded
- PNRG 1973
- ABEO N/A
- Country
- PNRG United States
- ABEO United States
- Employees
- PNRG N/A
- ABEO N/A
- Industry
- PNRG Oil & Gas Production
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PNRG Energy
- ABEO Health Care
- Exchange
- PNRG Nasdaq
- ABEO Nasdaq
- Market Cap
- PNRG 207.8M
- ABEO 277.6M
- IPO Year
- PNRG N/A
- ABEO 1980
- Fundamental
- Price
- PNRG $165.99
- ABEO $6.74
- Analyst Decision
- PNRG
- ABEO Strong Buy
- Analyst Count
- PNRG 0
- ABEO 3
- Target Price
- PNRG N/A
- ABEO $18.00
- AVG Volume (30 Days)
- PNRG 8.6K
- ABEO 270.0K
- Earning Date
- PNRG 11-15-2024
- ABEO 11-11-2024
- Dividend Yield
- PNRG N/A
- ABEO N/A
- EPS Growth
- PNRG 29.50
- ABEO N/A
- EPS
- PNRG 18.54
- ABEO N/A
- Revenue
- PNRG $178,705,000.00
- ABEO N/A
- Revenue This Year
- PNRG N/A
- ABEO N/A
- Revenue Next Year
- PNRG N/A
- ABEO $7,097.06
- P/E Ratio
- PNRG $9.00
- ABEO N/A
- Revenue Growth
- PNRG 56.70
- ABEO 147.52
- 52 Week Low
- PNRG $92.40
- ABEO $3.05
- 52 Week High
- PNRG $174.98
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- PNRG 64.95
- ABEO 66.23
- Support Level
- PNRG $157.51
- ABEO $6.15
- Resistance Level
- PNRG $166.75
- ABEO $6.74
- Average True Range (ATR)
- PNRG 6.18
- ABEO 0.32
- MACD
- PNRG 0.97
- ABEO -0.00
- Stochastic Oscillator
- PNRG 76.17
- ABEO 95.51
About PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and provide well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.